DMS Imaging (XBRU:ALIMG) Cash-to-Debt : 0.29 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is DMS Imaging Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. DMS Imaging's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.29.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, DMS Imaging couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for DMS Imaging's Cash-to-Debt or its related term are showing as below:

XBRU:ALIMG' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.19 Med: 0.92 Max: No Debt
Current: 0.29

During the past 12 years, DMS Imaging's highest Cash to Debt Ratio was No Debt. The lowest was 0.19. And the median was 0.92.

XBRU:ALIMG's Cash-to-Debt is ranked worse than
89.55% of 1540 companies
in the Biotechnology industry
Industry Median: 6.485 vs XBRU:ALIMG: 0.29

DMS Imaging Cash-to-Debt Historical Data

The historical data trend for DMS Imaging's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

DMS Imaging Cash-to-Debt Chart

DMS Imaging Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.75

0.54

0.19

0.32

0.29

DMS Imaging Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															0.19	0.26	0.32	0.23	0.29

Competitive Comparison of DMS Imaging's Cash-to-Debt

For the Biotechnology subindustry, DMS Imaging's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DMS Imaging's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DMS Imaging's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where DMS Imaging's Cash-to-Debt falls into.

DMS Imaging Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

DMS Imaging's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	5.159	/	(6.058	+	11.863)
	=	0.29

DMS Imaging's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	5.159	/	(6.058	+	11.863)
	=	0.29

DMS Imaging (XBRU:ALIMG) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

DMS Imaging Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of DMS Imaging's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

DMS Imaging (XBRU:ALIMG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DMS Imaging SA (XBRU:ALIMG) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

AS0:Germany

Address

7 Rue des Chasseurs Ardennais, Liege, BEL, 4031

Website

https://www.dms-imaging.com

DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

DMS Imaging (XBRU:ALIMG) Headlines

No Headlines